Effects of Vitamin D on asprosin and meteorin-like protein in liver tissue of diabetic rats
Ahmet Turk, Tuba Ozcan Metin.
Abstract
Diabetes mellitus (DM), a considerable concern for public health, serves as a predisposing factor for numerous diseases. Asprosin and meteorin-like protein (metrnl) are two peptides that play essential roles in glucose and energy metabolism. This study investigated the possible therapeutic potential of vitamin D (Vit D) against diabetes-induced liver damage in terms of asprosin and metrnl proteins. The study comprised four distinct groups: control, DM (60 mg/kg streptozotocin), Vit D (200 IU/kg), and DM+Vit D. Asprosin and metrnl levels were determined using both ELISA and immunohistochemical methods. Additionally, Total Oxidant Status (TOS) and Total Antioxidant Status (TAS) levels were assessed using the ELISA method. Asprosin and TOS levels increased in the DM group, whereas TAS and metrnl levels decreased. In the DM+Vit D group, metrnl levels increased while asprosin and TOS levels decreased significantly. These findings suggest that Vit D had protective effects against diabetes-induced liver damage and improved asprosin and metrnl levels. It has been concluded that Vit D could be considered as an attractive therapeutic agent target for asprosin and metrnl, which have positive effects on diabetes.
Key words: Asprosin, diabetes, meteorin-like factor, streptozotocin, Vitamin D
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
